Table 1

Baseline Clinical Characteristics of the Study Groups

Chronic Total Occlusionp Value
Yes (n = 278; 41.2%)No (n = 397; 58.8%)
Age, yrs65.4 ± 10.563.9 ± 10.60.07
Males, %84.979.30.06
Body mass index, kg/m227.9 ± 4.827.7 ± 4.30.62
Hypertension, %58.259.10.94
Diabetes, %50.043.10.07
Hyperlipidemia, %45.044.30.87
Current smoking, %38.838.50.93
Prior myocardial infarction, %77.066.2<0.01
Prior PCI, %70.168.80.66
Prior CABG, %38.125.9<0.01
Prior stroke, %8.16.40.42
Chronic kidney disease (class ≥3), %32.030.20.62
Atrial fibrillation, %27.726.20.66
ICD/CRT-D implanted, %64.761.50.38
Remote monitoring, %30.932.20.71
ACE inhibitor, %74.175.80.62
Beta-blocker, %95.096.00.62
Aldosterone receptor blocker, %80.182.80.36
Statin, %90.585.10.03

Values are mean ± SD or %.

ACE = angiotensin converting enzyme; CABG = coronary artery bypass grafting; CRT-D = cardiac resynchronization therapy-defibrillator; ICD = implantable cardioverter-defibrillator; PCI = percutaneous coronary intervention; SD = standard deviation.